Skip to the page

Data / Form D filings / Ganderland & Associates, Inc.

Ganderland & Associates, Inc.: Form D filing

Ganderland & Associates, Inc., a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2015. The latest, on October 14, 2015, reports $10,000 sold of a $1 million offering to 1 investor.

Find out what Ganderland & Associates, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
200 PARK AVENUE, SUITE 1700, New York, NY, 10166
Phone
(646) 632-3719
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
New York
Year incorporated
2015
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1655369

The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 14, 2015New notice$1,000,000$10,000$990,0001Oct 9, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Georgianna LandExecutive Officer, Director
Felice Jone-LeeExecutive Officer
Nicholas AndersonExecutive Officer

Other pharmaceuticals companies in New York that filed recently

Every Form D from the week of Oct 12, 2015 · All recent filings in New York · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Ganderland & Associates, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.